Cite
HARVARD Citation
Chen, W. et al. (2023). Successful administration of low-dose almonertinib in a patient with lung adenocarcinoma after osimertinib-induced interstitial lung disease: a case report and literature review. Anti-cancer drugs. 34 (3), pp. 460-466. [Online].